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 ABSTRACT 
Cephradine is a first-generation cephalosporin antibiotic and can be used to treat different infectious diseases from both gram-positive and gram-negative microorganisms. 
From other studies it has been reported that cephradine can form at least 4 anhydrous polymorphs, one monohydrate and one dihydrate [1]–[4], which lead to significant chal-
lenges in the crystallization process as the product has to be crystallized with the desired solid form and the preferred particle size and shape. 
 
In the current work, the relative stability of the anhydrate/monohydrate cephradine (CPA/CPH) as a function of temperature and water activity in the sur-
rounding medium is investigated. This is investigated by measuring the solubility of CPA/CPH in different methanol-water mixtures at varying temperatu-
res 15-55 °C. The solid phase is analyzed by Raman spectroscopy to identify which solid form is obtained under the given methanol-water mixture and 
temperature conditions. It is observed that the CPH transforms to the CPA at methanol mole fractions greater than 0.65 and that the CPA is a different poly-
morph than the anhydrous cephradine, purchased from Sigma-Aldrich. Subsequently, crystallization behavior of cephradine polymorphs and hydrates is 
studied by linear cooling crystallizations. Different operating conditions are investigated such as the effect of cooling rate and use of different solvent mix-
tures of water and methanol.  
 
The obtained results can be used to predict the relative stability of the CPA/CPH at different temperatures and water activity in the surrounding medium. Furthermore, the obtained know-
ledge regarding the crystallization behavior of the different solid forms of cephradine can be used in the design and development of crystallization processes to yield the desired solid 
phase of cephradine. 
Figure 1: Cephradine structure 
 
CONCLUSIONS 
• Solubility of cephradine increases with temperature and water mole fraction 
• CPH transforms into CPA at a mole fraction <0.4 of water and methanol 
• Cooling crystallization of cephradine showed that the MSZW increases with cooling 
rate in pure water and with mole fraction of methanol in the solvent 
• CPH was formed in all cooling crystallization experiments 
 
FUTURE PROCEEDINGS 
•  Further optimization of crystal product obtained from the cooling crystallization to 
gain free flowing crystals and good filtration abilities. 
• Investigate the crystallization of the anhydrous form of cephradine 
• Implementation of process analytical tools (PAT) to control and analyze the cooling 
crystallization 
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EKSPERIMENTAL SETUP  
Solubility and stability measurement:  
• Classical isothermal technique 
• Temperature: 15, 25, 35, 45 and 55 °C 
• Time: 6 hours  
• Solvents: Water and Methanol 
• Saturated solution analyzed with HPLC 
• Three repetitions 
• Starting material: Cephradine monohydrate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterization of cephradine:  
 
 
 
 
 
 
 
 
 
 
 
 
 
Cooling crystallization:  
• Cooling at constant rate  
• Performed in an EasyMax 102  
• Scale 100 mL  
• Overhead stirrer and solid state thermostat 
• Nucleation is detected by monitoring the turbidity of so-
lution  
• The Meta Stable Zone Width (MSZW) is measured 
 
 
 
 
 
 
 
 
 
 
Figure 2: Experimental setup for the 
solubility measurements 
Figure 3: Raman spectroscopy 
Figure 4: X-ray Powder Difraction (XRPD) 
Figure 5: Experimental setup for crystallization experiments and 
cooling procedure derived from solubility experiments at 55 °C. 
Theoretical yield of 76 % 
 
RESULTS 
Solubility and stability measurement: 
 
Cooling crystallization:  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7:  Effect of cooling rate on MSZW of  
cephradine 
Figure 8:  Effect of solvent composition of wa-
ter and methanol on MSZW of  cephradine 
Cooling rate Solvent composition  
1 °C/min 0.5 °C/min 0.1 °C/min 0.1 MeOH  0.3 MeOH 0.5 MeOH 
Filtration rate (g/min) 0.25 0.27 2.72 1.44 1.39 1.62 
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Figure 6: Solubility of cephradine in different solvent mixtures of water and methanol at different 
temperatures 
Cephradine monohydrate 
Cephradine anhydrate 
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